Waiting for answer This question has not been answered yet. You can hire a professional tutor to get the answer.
Question

Analysis of diabetes disease Introduction Pathophysiology examines how diseases affect how our body functions. Healthcar

Analysis of diabetes disease Introduction Pathophysiology examines how diseases affect how our body functions. Healthcare providers better care for patients when they understand how diseases affect their bodies. One needs pathophysiology knowledge to comprehend diabetes and its body effects. Diabetes damages the body by causing an ongoing problem where the body fails to adequately control blood sugar levels through insulin production. There are two main types of diabetes types one and two. In patients who develop Type one diabetes the immune system targets and destroys the cells that produce insulin in the pancreas. Type 2 diabetes occurs when regular insulin use becomes inefficient by body cells and blood glucose levels steadily increment. Advanced practice nurses rely on their diabetes training to both diagnose patients and take action to avoid other health complications. Healthcare workers should expand their diabetes education because this disease is becoming more widespread. Literature Review Diabetes is a result of a number of genetic, immune system, and environmental conditions. In T1DM, great chances are determined by genes of an individual, including those known as HLA-DR and HLA-DQ, who are predisposing to get an illness. Other environmental factors, such as viral infections and ingestion of some foods during childhood, may create antibodies that target and destroy the insulin-producing cells in the pancreas. In contrast, T2DM has a relation to family history, obesity, and sedentary lifestyle. It has also been identified that in some individuals, certain genes, such as TCF7L2 and FTO, increase a person’s chances of developing insulin resistance. (Bielka et al. 2022). T1DM occurs when the body’s defense mechanism, or the immune system, launches an attack on the insulin-creating cells in the pancreas. A person living with T1DM has autoantibodies in his/her blood that indicate the body’s immune system is actively attacking it. These autoantibodies act against insulin and other proteins such as GAD 65 and IA-2 as well. In T2DM, what the body has is chronic low-grade inflammation, and the fact is that such does, in the long run, cause damage. TNF-α and IL-6 cause damage to cells and tissues in the body in a way that inhibits the ability of insulin to get the cells to respond properly in order to lower circulating glucose levels. (Guo et al. 2023). Furthermore, the function of genes known as epigenetic means by which one can prepare for change or literally alter the genes can also predispose an individual to the disease. These genetic changes can be amplified by other factors like choosing foods rich in fats and taking little or no exercise to show complications with blood sugar regulation.

Pathogenesis

Diabetes emerges through a combined effect of genetic inheritance and exposure to environmental factors plus immunity issues. Type 1 diabetes occurs more frequently in people who inherit particular genetic traits. The immune system damages insulin-making cells unintentionally, leading to low insulin production or none at all in the body. The body develops diabetes because insulin deficiency stops sugar from being used as energy and leads to elevated blood sugar levels. (Stumvoll et al. 2008).

T2DM develops because insulin stops working effectively as the body cells resist its actions. The body blocks insulin signals at three key locations: muscles, the liver, and body fat. When the pancreas fails to produce enough insulin, the organ increases its insulin production output. Prolonged pancreatic cell strain causes insulin production to decline and produces abnormal increases in blood sugar levels. Fat storage and inflammation in our liver and muscle tissues reduce insulin's effectiveness. The PI3K/Akt and MAPK pathways actively support body functions of T2DM by controlling sugar uptake and cell development. The breakdown of these cell-signaling pathways creates insulin resistance and health difficulties.

Clinical Correlation

Diabetes symptoms result directly from how diabetes develops and progresses. The medical condition T1DM develops when insulin-producing cells get damaged and causes people to urinate more often, feel strongly thirsty, lose weight, and feel exhausted. People with type 1 diabetes experience an increased risk of developing celiac disease and thyroid disease because type 1 diabetes results from an autoimmune response. The signs of T2DM include tiredness alongside eye clarity issues and repeated infections because the body cannot make enough insulin and resist the insulin it receives effectively. Individuals with T2DM typically gain excess weight and develop dark skin discoloration because their bodies resist insulin effects.

Doctors and nurses can better diagnose and treat diabetes when they understand its molecular processes. A test for autoantibodies helps doctors find T1DM patients before their full symptoms show up. People with T1DM can better control their diabetes through main treatment insulin therapy alongside modern insulin pumps and continuous glucose monitors. Patients with T2DM need to change their diet and exercise habits to help their body work better with insulin. Doctors use metformin and GLP-1 receptor agonists as medicines to control blood sugar levels through multiple metabolic actions in the body.

Conclusion

Embracing unhealthy lifestyle patterns while inheriting specific genes leads to diabetes and limits insulin's effectiveness. In Type 1 diabetes insulin-producing cells must endure damage to develop this condition yet Type 2 diabetes results from insulin resistance. Effective patient care depends on advanced practice nurses that are familiar on how diabetes changes the way the body functions. Medical staff use their understanding of diabetes biology to provide better help patients who have diabetes lead healthier lives.

References

Bielka, W., Przezak, A., & Pawlik, A. (2022). The role of the gut microbiota in the pathogenesis of diabetes. International journal of molecular sciences, 23(1), 480.

Guo, H., Wu, H., & Li, Z. (2023). The pathogenesis of diabetes. International journal of molecular sciences, 24(8), 6978.

Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2008). Type 2 diabetes: pathogenesis and treatment. The Lancet, 371(9631), 2153-2156.

Get your expert answer
The answer will appear once the tutor is done working on it.